drugset / Trial / NCT00817258

Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma

NCT00817258 ↗

Phase 2 Unknown 37 enrolled Fudan University
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to determine the overall survival in patients with stage II (T1-2N1M0) NPC treated with concurrent chemotherapy and radiotherapy. Secondary objectives of the study are to evaluate the disease free survival, and distant metastases free survival of patients with stage II NPC treated with this regimen

Timeline

Start
2007-01
Primary completion
2009-06
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 40 mg/m2 —